[Comparative immunohistochemical features of Crohn disease and ulcerative colitis].
The determination of markers of proliferation and apoptosis in cases of Crohn disease and ulcerative colitis enables to foresee the development of morphological pathological changes occurred in a colon mucosa.
Ioffe
A Iu
AIu
D000230:Adenocarcinoma / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D015415:Biomarkers / Q000032:analysis; D003093:Colitis, Ulcerative / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D003110:Colonic Neoplasms / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D003424:Crohn Disease / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D007413:Intestinal Mucosa / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D019394:Ki-67 Antigen / Q000032:analysis; D008297:Male; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D019014:fas Receptor / Q000032:analysis
D015415:Biomarkers; D019394:Ki-67 Antigen; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D019014:fas Receptor